Clinical Trial Update: Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

Phase 3 study evaluating varenicline for smoking cessation during the acute phase of COPD exacerbation has completed, reporting on its efficacy in this setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COPD Exacerbation
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: University Hospital, Brest | Conditions: Chronic Obstructive Pulmonary Disease, COPD Exacerbation | Phase 3 | Status: COMPLETED